Anti-BMP8A Antibody

Manufactured by Antibodies.com, this affinity-purified polyclonal reagent is raised in rabbit and specifically targets Bone Morphogenetic Protein 8A (BMP8A), detecting endogenous levels of the total protein via a synthetic peptide immunogen derived from the C-terminal region of the human target. The unconjugated IgG antibody is supplied as a 50 µl aliquot at 1.0 mg/mL, formulated in phosphate-buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, with 150 mM NaCl, 0.02% sodium azide, and 50% glycerol as a cryoprotectant. Validated applications include Western Blot (WB) and Immunocytochemistry/Immunofluorescence (ICC/IF), with reactivity confirmed against human samples. For routine handling, the vial is shipped at 4 °C and should be aliquoted upon arrival and stored at −20 °C, with repeated freeze/thaw cycles avoided to preserve activity. Produced under the supplier's standard quality controls and dispatched from Stockholm with a typical lead time of 5–8 business days, this antibody is intended for research use only and is not suitable for diagnostic or therapeutic applications.